Dr. Mark L. Sturdevant, MD

Dr. Sturdevant practices at Keck Hospital of USC in Los Angeles, California, part of University of Southern California.

Dr. Sturdevant's NPI, 1992894075, was assigned on October 12, 2006. Dr. Sturdevant graduated from Carver College of Medicine in 1999. Dr. Sturdevant's Washington license number on file is MD61025436.

Dr. Sturdevant's primary practice is Keck Hospital of USC, at 1500 San Pablo Street, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 442-8656.

Dr. Sturdevant's primary practice is Keck Hospital of USC in Los Angeles, California, part of University of Southern California. Dr. Sturdevant is also affiliated with UW Medical Center - Montlake. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Sturdevant to 1 more other site, 1 urgent care center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sturdevant practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Sturdevant's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Sturdevant is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Sturdevant's licenses on file in 6 states: Washington, California, Pennsylvania, New York, Minnesota and North Carolina.

CMS data shows 48 Medicare services from Dr. Sturdevant across 2 procedure codes in 2024, for 41 Medicare patients. Medicare paid $5,337 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 41 Medicare patients who saw Dr. Sturdevant in 2024. The largest group is 65 to 74, with 24 patients. 75% of them have high blood pressure, and 54% have alcohol and drug use disorders. 29% are also on Medicaid. Their average risk score is 3.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sturdevant's median patient age at 57, with 41% women.

In 2024, Dr. Sturdevant wrote 191 Medicare Part D claims for 25 patients. 78% of them were for generic drugs. CMS names the drug for 77 of them, across 5 drugs with 11 or more claims each, at $6,668 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Sturdevant for performance year 2024, reported through an alternative payment model (APM).

Dmand AI links 10 papers to Dr. Sturdevant, published from 2021 to 2025. 2023 was the busiest year, with 3. The most frequent topics are Liver Transplantation, Living Donors and End Stage Liver Disease. Dr. Sturdevant has published most often in Pediatr Transplant. Dr. Sturdevant's most frequent co-authors are Patrick J. Healey, MD, James D. Perkins and Evelyn K. Hsu, MD.

CMS Open Payments shows 11 general payments to Dr. Sturdevant from 4 drug and device companies from 2024 to 2025. Travel and lodging make up the largest share, 73% of the total. Intuitive Surgical, Inc. paid the most, $1,121.

Dr. Sturdevant graduated from Carver College of Medicine in 1999.

Dr. Sturdevant is in network with 11 carriers, including Aetna, United Healthcare and HCSC. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.